Jeff Ajer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]

Bert brian muellerAlexander hardyGreg guyerJeff ajerHank fuchsInvestor relationsChief executive officerExecutive vice presidentChief financialChief commercial officerChief technical officerInvestor dayBiomarin pharmaceuticalExecutive vice president

Nektar Therapeutics : SCHEDULE 14A - MarketScreener

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

United statesSan franciscoJeff ajerRoya whitfieldComputershare incBroadridge financial solutions incAudit committeeCorporate governance committeeSecurities exchangeExchange actExchange commissionBank or other agentNektar therapeuticsErnst youngStatement pursuantCommission only

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript

BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44.

United statesGreg guyerSalveen richterAlexander hardyJeff ajerJessica fyeHenry fuchsAkash tewariTraci mccartyHank fuchsBrian muellerGoldman sachsBiomarin pharmaceutical incBiomarin pharmaceuticalCall transcript februaryMarin pharmaceutical

Rx Rundown: BridgeBio Pharma, Vertex Pharmaceuticals, Allakos and more

Check out this week’s medical marketing news, people on the move and industry chatter.

United statesAlpha teknovaJames kovachCarl icahnWilliam grossmanCarolyn bartholdsonAerin omalleyBridgebio pharmaJeff ajerLegochem biosciencesSusan goodell gouardAgepha pharmaVivek ramaswamyAlice choiAndrei floroiuScott gottlieb

BioMarin Pharma (BMRN) Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN for Severe Hemophilia A in Germany

BioMarin Pharma (BMRN) Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN for Severe Hemophilia A in Germany
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jeff ajerItalian medicines agencyBiomarin pharmaceutical incBiomarin pharmaceuticalGerman national associationStatutory health insurance fundsGerman haemophilia registry